Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malaria (Plasmodium Falciparum)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT04327310
What this trial is testing

Clinical Study of Meplazumab to Treat With Malaria

Who this might be right for
Malaria (Plasmodium Falciparum)
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd
Testing effectiveness (Phase 2)UnknownNCT03697668
What this trial is testing

Triple Antimalarial Combination to Accelerate the Parasite Clearance and to Prevent the Selection of Resistant Parasites

Who this might be right for
Plasmodium Falciparum Malaria (Drug Resistant)
Nurex S.r.l. 50
Large-scale testing (Phase 3)Study completedNCT00289250
What this trial is testing

Effect of Antimalarial Treatment on Gametocyte Carriage in Asymptomatic P. Falciparum

Who this might be right for
Asymptomatic P.Falciparum Malaria
London School of Hygiene and Tropical Medicine 360
Not applicableStudy completedNCT00544024
What this trial is testing

Mefloquine Bioequivalence Among 3 Commercially Available Tablets.

Who this might be right for
Malaria
Centers for Disease Control and Prevention 39
Testing effectiveness (Phase 2)Study completedNCT00341250
What this trial is testing

Malaria Vaccine in Children in Mali

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 900
Large-scale testing (Phase 3)Study completedNCT03640403
What this trial is testing

Effectiveness and Safety of Intermittent Preventive Treatment for Malaria Using Either Dihydroartemisinin-piperaquine or Artesunate-amodiaquine in Reducing Malaria Related Morbidities and Improving Cognitive Ability in School-aged Children in Tanzania

Who this might be right for
Malaria,FalciparumAnemia
National Institute for Medical Research, Tanzania 1,555
Testing effectiveness (Phase 2)Ended earlyNCT01024686
What this trial is testing

Phase 1/2a Trial of Pf GAP p52-/p36- Sporozoite Malaria Vaccine

Who this might be right for
Malaria
Seattle Children's Hospital 6
Testing effectiveness (Phase 2)Study completedNCT03138096
What this trial is testing

Safety and Protective Efficacy of Pb(PfCS@UIS4)

Who this might be right for
Malaria,FalciparumPlasmodium FalciparumPlasmodium Berghei+1 more
Radboud University Medical Center 24
Post-approval studies (Phase 4)Study completedNCT02637128
What this trial is testing

In Vivo Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine for Uncomplicated P. Falciparum Malaria

Who this might be right for
MALARIA, FALCIPARUM
Centers for Disease Control and Prevention 452
Large-scale testing (Phase 3)Study completedNCT00118807
What this trial is testing

Trial of the Effectiveness of AQ/AS, SP/AQ and SP/CQ for Uncomplicated Malaria in Gambian Children

Who this might be right for
Malaria
London School of Hygiene and Tropical Medicine 1,800
Post-approval studies (Phase 4)Study completedNCT01023399
What this trial is testing

Artesunate Plus Amodiaquine in Malaria in Cote d'Ivoire

Who this might be right for
Malaria
Sanofi 580
Early research (Phase 1)Study completedNCT02132299
What this trial is testing

Dose Escalation, Randomized Controlled Trial to Evaluate the Safety, Immunogenicity and Efficacy of Intravenously Administered Attenuated Plasmodium Falciparum Sporozoite Vaccine (PfSPZ Vaccine) in Tanzanian Adults

Who this might be right for
MalariaPlasmodium Falciparum Malaria
Sanaria Inc. 67
Post-approval studies (Phase 4)Study completedNCT04565184
What this trial is testing

Effectiveness and Safety of Artesunate-Amodiaquine and Artemether-Lumefantrine for the Treatment of Malaria in Yaounde

Who this might be right for
Malaria,Falciparum
University of Yaounde 1 242
Not applicableStudy completedNCT06970600
What this trial is testing

Efficacy of Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Under 12 Years at Four Sentinel Sites in Mozambique

Who this might be right for
Malaria (Uncomplicated)
Centro de Investigacao em Saude de Manhica 352
Post-approval studies (Phase 4)UnknownNCT02297477
What this trial is testing

The ASAP Study - Therapeutic Efficacy of Atovaquone-proguanil vs. Artesunate-atovaquone-proguanil in Cambodia

Who this might be right for
Malaria
Armed Forces Research Institute of Medical Sciences, Thailand 205
Early research (Phase 1)Study completedNCT03261401
What this trial is testing

First-in-Human Trial of Single Ascending Dose, Multiple Ascending Dose and Malaria Challenge Model in Healthy Participants

Who this might be right for
Healthy
Merck KGaA, Darmstadt, Germany 88
Post-approval studies (Phase 4)Study completedNCT03783299
What this trial is testing

Targeted Active Case Detection Among High Risk Populations in Southern Lao Peoples Democratic Republic

Who this might be right for
Plasmodium Falciparum Malaria
University of California, San Francisco 39,968
Testing effectiveness (Phase 2)Study completedNCT02831023
What this trial is testing

Phase 2 Efficacy Study of Primaquine and Methylene Blue

Who this might be right for
Malaria
University of California, San Francisco 80
Post-approval studies (Phase 4)Study completedNCT00935688
What this trial is testing

Examination of ACT Implementation in a Vivax / Falciparum Co-endemic Area

Who this might be right for
MalariaFever
London School of Hygiene and Tropical Medicine 4,200
Post-approval studies (Phase 4)Study completedNCT00540410
What this trial is testing

Cohort Study in Senegal Comparing Artesunate + Amiodaquine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks

Who this might be right for
Malaria
Sanofi 366
Next Page